|
Match
|
Document |
Document Title |
|
|
7622575 |
Therapeutic uses of glucan
The present invention is directed to methods of using glucan compositions, comprising water insoluble microparticulate glucans, in the treatment of connective tissue injuries. The water insoluble...
|
|
|
7612048 |
Quick water-dissolving film containing cosmetic, aromatic, pharmaceutical or food substances
Film with high solubility in water, comprising a starch, a cellulose and a cosmetic, aromatic, pharmaceutical and/or food substance in a quantity exceeding 10% on the total film weight.
|
|
|
7608708 |
Monocotyledon plant cells and plants which synthesize modified starch
The present invention relates to monocotyledon plant cells and plants which are genetically modified, wherein the genetic modification consists of the introduction of an extraneous nucleic acid...
|
|
|
7601705 |
Polymer controlled induced viscosity fiber system and uses thereof
The present invention relates generally to a method of blunting the postprandial glycemic response in a human by feeding an induced viscosity fiber system. The invention also relates to an induced...
|
|
|
7579017 |
Physical mode of action pesticide
A physical mode of action pesticide for application on plants and in soils, and methods of manufacture and application, comprising an active ingredient in the form of a polymer in a concentration...
|
|
|
7569557 |
Compositions of estrogen-cyclodextrin complexes
Pharmaceutical compositions comprising low doses of sensitive complexes between an estrogen and a cyclodextrin are provided with improved stability. In specific embodiments the composition...
|
|
|
7569556 |
Method of use of carboxylated polysaccharides topically on the eyeball
The use of chemically modified dicarboxy polysaccharides for the topical treatment of the eyeball are described. The modified polysaccharides provide a carrier in solutions for the treatment of the...
|
|
|
7560443 |
Mixtures of fructose, sucrose and lactose as a low-calorie bulk sweetener with reduced glycemic index
Mixtures of fructose and lactose are useful for reducing caloric intake and glycemic index for individuals who are overweight, glucose-impaired, diabetic, or who just consume too large a fraction...
|
|
|
7550447 |
Method for precipitating nucleic acid with visible carrier
A suitable carrier molecule useful in a nucleic acid precipitation method is modified by coupling a suitable visualizable indicator molecule to the carrier molecule. The conjugated carrier...
|
|
|
7550446 |
Highly branched, unsubstituted or low-substituted starch products, dialysis solution and plasma expander containing the same, and the use thereof
Known hydroxyethylated and -propylated starch types for use as colloid osmotic agent in peritoneal dialysis or as volume replacement composition (plasma expander) have the disadvantage that...
|
|
|
7491709 |
Treatment with hyaluronic acid
The present invention relates, generally, to methods of providing long-term minimization of wrinkles or folds in the skin by injecting a bolus of hyaluronic acid deep into the skin. The methods of...
|
|
|
7476660 |
Composition and method for organ preservation
The present invention relates to a composition for organ preservation, comprising an inulin type fructan as an active ingredient. The composition for organ preservation can suppress the...
|
|
|
7473776 |
Soluble hydrogenated starch derivatives containing nondigestible dietary fibres
The invention relates to soluble hydrogenated starch derivatives containing nondigestible dietary fiber, characterized in that they have an ICUMSA coloration value reduced by at least 50%, and a...
|
|
|
7425548 |
Materials and methods for immune system stimulation
The subject invention concerns a novel polysaccharide. RR1 is an α-D-glucan polysaccharide composed of a (1→4) linked back bone and (1→6) linked branches, which has been isolated from a...
|
|
|
7393841 |
Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods, especially for use as a plasma volume expander
The invention relates to the use of hyperbranched amylopectin which has an average branch degree of between >10 and 25 mol % and a molecular weight (Mw) ranging from 40.000-800.000 Dalton and...
|
|
|
7345029 |
Solution for peritoneal dialysis
The present invention relates to a solution for peritoneal dialysis, consisting of at least two single solutions which are combined after a heat sterilization and are administered to a patient, the...
|
|
|
7320962 |
Hemoactive compositions and methods for their manufacture and use
Dried hemoactive materials comprise both a cross-linked biologically compatible polymer and a non-cross-linked biologically compatible polymer. The cross-linked polymer is selected to form a...
|
|
|
7297687 |
Method of treating infectious diseases with polysaccharide derivatives
The present invention relates to a method of treating infectious diseases, that involves: (a) providing an alpha-glycosidically linked starch polysaccharide derivative; and (b) inhibiting the...
|
|
|
7291607 |
Isomaltooligosaccharides from Leuconostoc as neutraceuticals
Isomaltooligosaccharides (IMOs) produced by Leuconostoc mesenteroides ATCC 13146 fermentation with a sucrose:maltose ratio of 2:1 have been discovered to be effective prebiotics in mixed cultures...
|
|
|
7271158 |
Treatment of rumen acidosis with α-amylase inhibitors
The invention described herein relates to: the use of an effective inhibitor of a bacterial α-amylase and/or α-glucosidase in the manufacture of a composition for the treatment of acidosis; a...
|
|
|
7196073 |
Imine-forming polysaccharide adjuvants and immunostimulants
The present invention relates to polysaccharide conjugates that comprise: a polysaccharide that binds to surface-receptors present on Antigen Presenting Cells, conjugated to one or more compounds...
|
|
|
7183266 |
Dual induced viscosity fiber system and uses thereof
The present invention relates generally to a method of blunting the postprandial glycemic response to a meal by feeding a dual induced viscosity fiber system. The first component of the induced...
|
|
|
7115586 |
Non-inclusion cyclodextrin complexes
The invention provides a number of methods for enhancing the aqueous solubility of an active ingredient which is insoluble or sparingly soluble in water. In one preferred embodiment, solubilization...
|
|
|
7101862 |
Hemostatic compositions and methods for controlling bleeding
The invention provides hemostatic compositions useful to promote hemostasis at active bleeding wound sites. The hemostatic compositions typically include an article containing cellulose, e.g.,...
|
|
|
7097831 |
α-Amylase-resistant starch for producing foodstuff and medicaments
The invention relates to foodstuff and animal feed which contain resistant starch on the basis of water-insoluble linear α-1,4-D-glucans. The invention also related to the utilization of resistant...
|
|
|
7084132 |
Artemisinins with improved stability and bioavailability for therapeutic drug development and application
A stable form of artemisinin wherein an artelinic acid or artesunic acid is complexed with cyclodextrin analogs, preferably, β-cyclodextrin. The complexed cyclodextrin artemisinin formulation...
|
|
|
7084112 |
Activated polyethylene glycol compounds
Novel arylisothiocyanate compounds are described that are useful for activating alcohol-containing macromolecules, for example polyethyleneglycols and cellulose, for covalent linkage to...
|
|
|
7084107 |
Methods for stabilizing liquid nutritional products and products so stabilized
Nutritional solutions and methods of making same are disclosed. The solutions include protein, lipid, and a carbohydrate source including high amylose starch and guar gum.
|
|
|
7067498 |
Polymer controlled induced viscosity fiber system and uses thereof
The present invention relates generally to a method of blunting the postprandial glycemic response in a human by feeding an induced viscosity fiber system. The invention also relates to an induced...
|
|
|
7049339 |
Composition for the treatment of diseases which affect animals' hooves
A composition for treating a disease affecting the hoof of an animal comprising an active ingredient and a colloid former is described. The active ingredient may comprise zinc sulphate, copper...
|
|
|
7041655 |
Capillary membrane stabilization and reduction of tissue injury through use of IV biodegradable macromolecules with antioxidants and/or other chemicals
In accordance with the invention there is provided a method of treating a human subject to prevent leakage of serum proteins from capillary endothelial junctions during a period of increased...
|
|
|
7015200 |
Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
The present invention provides compositions comprising at least one GHB moiety bonded to at least one physiologically compatible carrier molecule. The compositions can enhance the uptake of the...
|
|
|
7008935 |
Amine, amide, sulphonamide and carbamate derivatives of benzalmalonic salts and photoprotective cosmetic compositions comprised thereof
Stable, topically applicable cosmetic/dermatological sunscreen compositions, well suited for the UV-photoprotection of human skin/keratinous materials, contain a thus effective amount of at least...
|
|
|
7001893 |
Inclusion complex of Rifampicin, an anti-tubercular drug, with β-cyclodextrin or 2-hydroxypropyl β-cyclodextrin and a process thereof
The present invention relates to an inclusion complex of Rifampicin and cyclodextrin (CD) that can be used as an anti-tubercular drug. The present invention also relates to a process for...
|
|
|
6982254 |
Compositions comprising a plurality of particles or agglomerates having a defined particle size
The present disclosure provides compositions comprising an extracted portion of psyllium seed in combination with one or more of a binder or edible acid. In particular, the present invention is...
|
|
|
6969706 |
Preserved pharmaceutical compositions comprising cyclodextrins
A composition comprising a cyclodextrin, a guanidine-based cationic compound, and sorbic acid is disclosed herein. Preservatives and methods related thereto, and experimental results suggesting...
|
|
|
6958326 |
Cyclodextrin-drospirenone inclusion complexes
Pharmaceutical compositions comprising low doses of sensitive complexes between an estrogen and a cyclodextrin are provided with improved stability. In specific embodiments the composition...
|
|
|
6953592 |
Water soluble powders and tablets
The invention relates to water soluble or water dispersible powders, tablets, or precursors therefor based on a carbohydrate matrix with improved dissolution properties in water. These components...
|
|
|
6946148 |
Method for absorbing fluid
Disclosed are a fluid absorber, a method for preparing a fluid absorber, and a method for absorbing fluid from the skin. The disclosed method for preparing a fluid absorber generally comprises the...
|
|
|
6943154 |
Water insoluble derivatives of polyanionic polysaccharides
A water insoluble, biocompatible composition that is formed by a method which combines, in an aqueous mixture, a polyanionic polysaccharide, a nucleophile, and an activating agent, under conditions...
|
|
|
6906043 |
Rapidly soluble film preparation
Disclosed is a rapidly soluble film preparation mainly comprising a drug, an edible polymer and a saccharide, a manufacturing method of which is simple, and having high elution rate.
|
|
|
6905702 |
Methods for regulating blood glucose and appetite suppression in type 2 diabetics
Methods are disclosed for treating a patient with Type 2 diabetes to decrease hypoglycemic episodes and/or to diminish fluctuations in blood glucose outside of the normal range, comprising...
|
|
|
6887859 |
Topical compositions containing fluid-absorbent solids and adhesive fluids
Disclosed are topical compositions, including methods of applying those compositions to absorb sweat and sebum from the skin, wherein the compositions comprise (A) fluid-absorbent solids having a...
|
|
|
6846497 |
Rapidly expanding starches with altered crystalline structure
This invention relates to a starch based tablet disintegrant useful at low addition levels and providing equally effective properties in water and physiological fluids. The starches are...
|
|
|
6844328 |
Polysaccharidic esters of N-derivatives of glutamic acid
The present invention is related to polysaccharide esters of N-derivatives of glutamic acid (N-GA derivatives). These polysaccharidic esters have antiproliferative activity and are characterized by...
|
|
|
6828334 |
Fenofibrate-cyclodextrin inclusion complexes and their pharmaceutical composition
The present invention relates to pharmaceutical compositions containing fenofibrate in the form of an inclusion complex with cyclodextrin, having high dissolution profile and in vivo enhanced...
|
|
|
6815436 |
Composition and method for the treatment of dysglucaemia
Dysglucaemia is treated and/or prevented by the administration of granulated starch, enzymatically degraded and releasing reducing sugars at a rate, adjusted to the metabolism of the patient,...
|
|
|
6812222 |
Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
The present invention relates to a peritoneal dialysis solution comprising at least one amino sugar in an effective amount sufficient to create an osmotic pressure to effect the removal of water by...
|
|
|
6790840 |
Reversibly cross-linked hydrogels
A hydrogel composition and methods of preparing and using the same are disclosed. The hydrogel composition comprises an oxidized polysaccharide, and a cross-linker having at least two functional...
|
|
|
6780852 |
Modified polysaccharides exhibiting altered biological recognition
The invention relates to polysaccharides, polysaccharide conjugates and complexes with altered biological properties, and methods to produce these polysaccharides, polysaccharide conjugates and...
|